Galectin 3 (Gal-3) has received significant attention for its utility as a diagnostic marker for thyroid cancer, being positive in thyroid carcinoma and negative in benign neoplasms and normal thyroid tissue (70). This evidence concerns the gene LGALS3 and thyroid gland carcinoma.